Oracle UCPM Content Integration Suite Developer Guide: 10g Relea...

4星 · 超过85%的资源 需积分: 10 2 下载量 180 浏览量 更新于2024-07-24 收藏 300KB PDF 举报
Oracle Universal Content Management (UCM) 是一个高度集成的内容管理解决方案,其核心是Content Integration Suite (CIS) API。这些API是UCM体系架构中的关键组件,它们提供了一种统一的接口,使得开发者能够与Content Server 进行交互并访问其丰富的数据和服务。CIS API设计为一系列Services API,每个API代表一个特定的功能或操作,如内容的检索、创建、更新和删除等。 在10g Release 3 (10.1.3.3.3) 版本的《Oracle Content Integration Suite Developer Guide》中,该文档详细介绍了如何利用这些API进行开发工作。主要作者Will Harris和贡献者Adam Stuenkel共同编撰了这份指南,确保开发者能够充分利用UCM的强大功能,同时保护了Oracle的知识产权。 使用UCPM API时,开发者需要注意以下几点: 1. **版权和许可协议**:所有的软件和文档都包含Oracle的专有信息,受严格的许可协议约束,禁止未经许可的复制、分发或公开披露。除非法律要求或为了与其他独立创建的软件实现互操作,否则解构、反编译或反汇编程序是被严格禁止的。 2. **文档更新**:文档内容可能会在未提前通知的情况下进行更改,因此在使用过程中,应保持与最新版本的同步,以便获取最新的指导和问题解决方案。 3. **错误声明**:尽管文档力求准确,但并不能保证无误。开发者在遇到问题时,应以书面形式向Oracle报告,以便及时修复。 4. **使用限制**:除在许可协议中明确规定的权限外,部分UCM程序的复制或传播可能是受限的,开发者需严格遵守这些规定。 《Oracle Universal Content Management Developer Guide》为CIS API的开发者提供了一个全面的参考资源,帮助他们开发高效、合规的应用程序,以整合和管理大量的内容数据。通过理解和掌握这些API,开发者能够更好地构建与Content Server无缝协作的系统,并优化内容管理工作流程。

润色下面英文:The controlled drug delivery systems, due to their precise control of drug release in spatiotemporal level triggered by specific stimulating factors and advantages such as higher utilization ratio of drug, less side-effects to normal tissues and so forth, provide a new strategy for the precise treatment of many serious diseases, especially tumors. The materials that constitute the controlled drug delivery systems are called “smart materials” and they can respond to the stimuli of some internal (pH, redox, enzymes, etc.) or external (temperature, electrical/magnetic, ultrasonic and optical, etc.) environments. Before and after the response to the specific stimulus, the composition or conformational of smart materials will be changed, damaging the original balance of the delivery systems and releasing the drug from the delivery systems. Amongst them, the photo-controlled drug delivery systems, which display drug release controlled by light, demonstrated extensive potential applications, and received wide attention from researchers. In recent years, photo-controlled drug delivery systems based on different photo-responsive groups have been designed and developed for precise photo-controlled release of drugs. Herein, in this review, we introduced four photo-responsive groups including photocleavage groups, photoisomerization groups, photo-induced rearrangement groups and photocrosslinking groups, and their different photo-responsive mechanisms. Firstly, the photocleavage groups represented by O-nitrobenzyl are able to absorb the energy of the photons, inducing the cleavage of some specific covalent bonds. Secondly, azobenzenes, as a kind of photoisomerization groups, are able to convert reversibly between the apolar trans form and the polar cis form upon different light irradiation. Thirdly, 2-diazo-1,2-naphthoquinone as the representative of the photo-induced rearrangement groups will absorb specific photon energy, carrying out Wolff rearrangement reaction. Finally, coumarin is a promising category photocrosslinking groups that can undergo [2+2] cycloaddition reactions under light irradiation. The research progress of photo-controlled drug delivery systems based on different photo-responsive mechanisms were mainly reviewed. Additionally, the existing problems and the future research perspectives of photo-controlled drug delivery systems were proposed.

2023-02-06 上传